sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
×ÔÈ»ÀÏ»¯¶¯ÎïÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Éúֳϵͳģ×Ó > ×ÔÈ»ÀÏ»¯¶¯ÎïÄ£×Ó

ǰÑÔ

Χ¾ø¾­ÆÚ(perimenopausal period)Ö¸´Ó¿¿½ü¾ø¾­·ºÆð¾ø¾­ÓйصÄÄÚÉøÍ¸¡¢ÉúÎïѧºÍÁÙ´²ÌØÕ÷ÆðÖÁ¾ø¾­Ò»ÄêÄÚµÄʱ´ú£¬¼´¾ø¾­ÓɶɯÚÖÁ¾ø¾­ºóÒ»ÄꡣΧ¾ø¾­ÆÚ×ÛºÏÕ÷ÊÇÓÉÓÚÂѳ²¹¦Ð§¼õÍË£¬µ¼Ö´Ƽ¤ËØÉøÍ¸ïÔÌ­£¬ÒýÆð»úÌåÄÚÉøÍ¸Ê§µ÷¡¢ÃâÒßÁ¦µÍϺÍ×ÔÖ÷Éñ¾­¹¦Ð§ÔÓÂÒµÄ×ÛºÏÕ÷¡£ÁÙ´²Éϳ£¼û³±ÈÈÀ亹¡¢Ô¾­ÔÓÂÒ¡¢¾«Éñ״̬µÄת±ä¡¢ÐÄѪ¹ÜÓëÉúÖ³ÃÚÄòϵͳ²¡±ä¼°¹ÇÖÊËÉÉ¢µÈÌåÏÖ¡£³£ÓõÄΧ¾ø¾­ÆÚ×ÛºÏÕ÷¶¯ÎïÄ£×ÓÓÐÂѳ²Õª³ýÄ£×Ó¡¢×ÔÈ»ÀÏ»¯Ä£×Ó¡¢XÏßËðÉËÂѳ²Ä£×ӵȡ£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î´óÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

12ÔÂÁäǰºó(11-13ÔÂÁ䣩µÄ´ÆÐÔ´óÊó£¬×îÏÈ·ºÆð¶¯ÇéÖÜÆÚÔÓÂÒ£¬ÑªÇåѧ¼°Âѳ²ÏìÓ¦µÄÉú»¯Ö¸±êµÈ¾ùÏÔʾ£¬¸Ã½×¶Î´óÊóÂѳ²µÄÉúÖ³¹¦Ð§³Ê¾ÙÐÐÐÔË¥Í˵ĸı䣬ÓëÅ®ÐÔΧ¾ø¾­ÆÚÌåÏÖ¼«ÎªÏàËÆ£¬¿É×÷ΪΧ¾ø¾­ÆÚÂѳ²ÐàÂõÑо¿µÄ¶¯ÎïÄ£×Ó¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

12ÔÂÁäǰºóµÄ´ÆÐÔSprague­Dawley´óÊó»òWistar´óÊóÈô¸ÉÖ»£¬Ò»Á¬ÒõµÀϸ°ûѧÊÓ²ì15Ì죬ѡȡ¶¯ÇéÖÜÆÚ·ºÆðÁËÑÓÉì¼°ÔÓÂÒÌåÏÖµÄΪģ×Ó×飬°üÀ¨¶¯ÇéÖÜÆÚÑÓÉ죬֮ºóÒ»Á¬¶¯Ç飬Öظ´¼ÙÈÑÉï¡£´óÊóÐÔ³ÉÊìºó£¬¶¯ÇéÖÜÆÚÿ¾­4~5ÖçÒ¹½ÚÂÉÐÔµØÖظ´Ò»´Î£¬ÔÚÕâ¸öÀú³ÌÖÐÂѳ²µÄÂÑÅÝ¡¢×Ó¹¬ºÍÒõµÀÉÏÆ¤¶¼ÂÄÀú×ÅÖÜÆÚÐÔµÄת±ä£¬¶¯ÇéÆÚ¿É¼û´ó¶øµ­È¾µÄÎ޺˽ǻ¯Ï¸°û£¬¶¯Çé¼äÆÚÒõµÀÉÏÆ¤Öð½¥Ôöºñ£¬Ï¸°û¼äÓÐÐí¶à°×ϸ°û¡£ÒõµÀÍÑÂäϸ°ûͿƬҪÁ죺×óÊÖ±³Î»Àο¿´óÊó£¬ÓÒÊÖ³ÖÎü¹Ü£¬ÆäÄÚÔ¤ÏÈÎüÈëÐÄÀíÑÎË®0.1~0.2ml¡£ÇáÇá²åÈë´óÊóÒõµÀÄÚ0.5~1cm£¬³éÎü2~3´Î£¬µÎÒ»µÎÎüÒºÓÚÔØ²£Æ¬ÉÏ¡£È»ºóµÎÒ»µÎ95£¥ÒÒ´¼ÈÜÒº£¬ÁÀ¸ÉºóÒÔ1£¥ÑǼ×À¶È¾É«10·ÖÖÓ£¬ÓÃË®³åÏ´¶àÓàȾҺ¡£´µ¸ÉºóÖÃÓÚÏÔ΢¾µÏ¾ÙÐÐϸ°ûѧ¼ì²é¡£ÖðÖ»¾ÙÐÐÒõµÀͿƬ¼ì²é£¬Ã¿1´Î£¬Ò»Á¬15Ìì¡£

¡¾Ä£×ÓÌØµã¡¿£º

1.Âѳ²×éÖ¯µÄÐÎ̬ѧÊÓ²ì

¢Å¹â¾µÊÓ²ìЧ¹û£ºÇàÄê±ÈÕÕ×é´óÊóÂѳ²·¢Óý³ÉÊ죬ƤÖÊ¡¢ËèÖÊÌõÀíÃ÷È·£¬ÆäÖи÷¼¶ÂÑÅݼ°»ÆÌåÊýÄ¿¾ù½Ï¶à£¬ÂÑÅÝÒº¸»ºñ£¬¿É¼ûÉÙÁ¿±ÕËøÂÑÅݼ°¼äÖÊÏÙ¡£Ä£×Ó×é´óÊóÂѳ²Î®Ëõ£¬·¢Óý½Ï²î£¬ËèÖÊÔö¶à£¬Ô­Ê¼ÂÑÅݺÍÉú³¤ÂÑÅݾùÏÔ×ÅïÔÌ­£¬¿ÅÁ£Ï¸°ûÅÅÁв»¹æÕû£¬¿É¼û¿ÅÁ£Ï¸°ûµÄ±À½â£¬Î´¼ûµä·¶µÄ³ÉÊìÂÑÅÝ£¬±ÕËøÂÑÅÝÊýÄ¿ÔöÌí£»³ÉÊì»ÆÌåÊýĿҲ½ÏÉÙ£¬¶øÍË»¯»ÆÌåÊýÄ¿Ôö¶à£¬¼äÖÊÏÙÉÙ¶øËÉÉ¢£¬¿É¼ûÏËά×éÖ¯ÔöÉú»ò±À½â£¬Ñª¹ÜÊýÄ¿ïÔÌ­£¬Ð¡¶¯Âö¹ÜÇ»ÏÁÕ­¡¢¹£Èû¡£

¢Æµç¾µÊÓ²ìЧ¹û£ºÇàÄê×é±ÈÕÕÂѳ²Ô­Ê¼ÂÑÅݸ»ºñ£¬ÂÑĸϸ°ûÌå»ý½Ï´ó£¬ºËÖÊÔȳơ¢ºËÈÊÏÔ×Å£¬ÖÜΧµ¥²ã¿ÅÁ£Ï¸°ûºË²»¹æÔò£¬ºËĤÄÚÓб¡²ãÒìȾɫÌ壻Éú³¤ÂÑÅÝÖпɼû͸Ã÷´øÔö¿í£¬¿ÅÁ£Ï¸°û³Ê¶à²ãÂþÑÜ£¬ºË´óµ­È¾£¬ºËÈÊÏÔ×Å£¬È¾É«ÖÊÔȳÆ£¬Ï¸°ûÆ÷ÍêÕû£¬ÂÖÀªÇåÎú£¬°ûÖÊÖÐϸ°ûÆ÷¸»ºñ£¬¿É¼ûÉøÍ¸¿ÅÁ££» ϸ°û¼äÓÐñ¼×´¼ä϶¡£Ä£×Ó×éÂѳ²¿ÅÁ£Ï¸°ûÖÐÓн϶à¿ÕÅÝ£¬ÉøÍ¸¿ÅÁ£ïÔÌ­£¬ÆäÖпɼûÖÂÃÜÎ»¬ÃæÄÚÖÊÍø²»¸»ºñ£¬Ï¸°û¼äµÄñ¼×´¼ä϶Ôö´ó£»¼äÖʿɼûÏËά¡¢»ùÖÊÏûÈÚ¡£

2.Ä£×Ó×éÓëÇàÄê±ÈÕÕ×éÏà±È£¬ÑªÇå´ÙÂÑÅÝÌìÉú¼¤ËØFSH¡¢´Ù»ÆÌåÌìÉúËØLH¡¢´ÙÐÔÏÙ¼¤ËØÊͷż¤ËØGnRHˮƽÉý¸ß£¬ÑªÇå´Æ¼¤ËØE2ˮƽ½µµÍ£»Ä£×Ó×é½ÏÇàÄê±ÈÕÕ×éÂѳ²Ö¸ÊýÓë×Ó¹¬Ö¸ÊýÏÔÖø½µµÍ£»ÒÔÉϾùÓÐÏÔÖø²î±ð(P<0.05)¡£

3.Χ¾ø¾­ÆÚ¸¾Å®ÓÉÓÚÂѳ²¹¦Ð§Ë¥ÍË£¬´Æ¼¤ËØË®Æ½Ï½µ£¬ÑªÖÐ×ܵ¨¹Ì´¼¡¢¸ÊÓÍÈýõ¥¡¢µÍÃܶÈÖ¬ÂѰ׵¨¹Ì´¼ÔöÌí¡£¶øÑªÖ¬´úлÒì³£Êǵ¼Ö¶¯ÂöÖàÑùÓ²»¯(atheroscbrasis)¡¢¹ÚÐIJ¡(coronary heart disease)µÄÖ÷ÒªÔµ¹ÊÔ­ÓÉ¡£±¾Ä£×Ó¶¯ÎïµÄѪÇå×ܵ¨¹Ì´¼¡¢ÑªÇå¸ÊÓÍÈýõ¥¡¢Ñªáú½éÃܶÈÖ¬ÂѰ׵¨¹Ì´¼¡¢ÑªÇåµÍÃܶÈÖ¬ÂѰ׵¨¹Ì´¼µÈˮƽ¾ùÓëÇàÄê×éÓÐÏÔÖø²î±ð£¬ºÜÊÇÇкÏΧ¾ø¾­ÆÚµÄÌØµã£¬±¾Ä£×ÓÊÇÀֳɵÄ¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

×ÔÈ»ÀÏ»¯Ä£×ÓÓëÈËΧ¾ø¾­ÆÚÉúÎïÑ§ÌØÕ÷Ïà·Â£¬ÓÐ×ÔÈ»µÄÐàÂõÀú³Ì£¬ÊÇÂѳ²¹¦Ð§µÄË¥½ß¶ø²»ÊÇÂѳ²Õª³ý£¨È¥ÊÆ£©£¬ÒÔÊǸü¿¿½üÓÚÊÂʵ×Ô¼º£¬ÊǽÏΪÀíÏëµÄÄ£×Ó¡£ÈõµãÊÇÖÜÆÚ³¤£¬Óöȸß¡£

 

²Î¿¼ÎÄÏ×£º

1.Íõ»ª¸»£¬Ðí»ÝÇÙ£¬³ÂÃôÃô£¬µÈ£®°ÙºÏ֪ĸÌÀ²î±ðÅä±È¶ÔÈ¥ÊÆÎ§¾ø¾­ÆÚ×ÛºÏÕ÷ÉöÒõÐéÖ¤´óÊó×Ó¹¬ÏµÊý¼°ÑªÇåÐÔ¼¤ËصÄÓ°Ï죮ÖлªÖÐÒ½Ò©ÔÓÖ¾£¬2010, 25 (4):531-535

2.ÇúÏÔ¿¡£¬´ÞÊçÏ㣬Àî·çÇÙ£¬µÈ£®¹ÇÎ¬ËØ×¢ÉäÒº¶ÔXÏßÖ´óÊó¸üÄêÆÚ×ÛºÏÕ÷Ä£×ÓµÄÖÎÁÆ×÷ÓÃÊӲ죮ɽ¶«Ò½Ò©¹¤Òµ£¬1998, 17 (4):123-128

3.ËïÑ޺죬½ðÈôÃô£®Å®ÐÔ¸üÄêÆÚ×ÛºÏÕ÷¶¯ÎïÄ£×ÓÖÆ±¸µÄÑо¿Ï£Íû£®Ê±Õä¹úÒ½¹úÒ©£¬2005, 16 (7):657-659

4.Ëï¾²·Ú£¬ÕÔìÇ£¬ÎâËØ»Û£®Î§¾ø¾­ÆÚ×ÛºÏÕ÷ʵÑ鶯ÎïÄ£×ӵĽÏÁ¿ÆÊÎö£®É½Î÷Ò½¿Æ´óѧѧ±¨£¬2007,38 (1):43-45

5.ÃÏÒ㣬ÅÓº£Ñ࣬Áõ¹úÒÕ£¬µÈ£®´ó¶¹Òì»ÆÍª¶ÔΧ¾ø¾­ÆÚ´óÊóÂѳ²×éÖ¯ÐÎ̬ѧת±ä¼°SPARCmRNA±í´ïµÄÓ°Ïì, ÖйúÖÐÒ½Ò©¿Æ¼¼£¬2012, 19(1):32-34

6.ÀµÇ«¿­£¬Õž²£¬ÕÅÏþµ¤£®°²¶È¸üÄêÍè¶ÔΧ¾ø¾­ÆÚSD´óÊóÐÔ¼¤Ëؼ°ÑªÖ¬´úлӰÏìµÄʵÑéÑо¿£®ÖÐÒ½ÁÙ´²Ñо¿£¬2012,4 (9):29-31

7.Bellino FL, Wise PM. Nonhuman primate models of menopause workshop. Biol Reprod, 2003, 68 (1):10-18

8.Mayer LP, Oyer CA, Eastgard RL, el al. Atherosclerotic lesion development in a novel ovary-intact mouse model of perimenopause. Arterioscler Thromb Vasc Biol, 2005, 25 (9):1910-1916

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Éúֳϵͳģ×Ó > ×ÔÈ»ÀÏ»¯¶¯ÎïÄ£×Ó
×ÔÈ»ÀÏ»¯¶¯ÎïÄ£×Ó

ǰÑÔ

Χ¾ø¾­ÆÚ(perimenopausal period)Ö¸´Ó¿¿½ü¾ø¾­·ºÆð¾ø¾­ÓйصÄÄÚÉøÍ¸¡¢ÉúÎïѧºÍÁÙ´²ÌØÕ÷ÆðÖÁ¾ø¾­Ò»ÄêÄÚµÄʱ´ú£¬¼´¾ø¾­ÓɶɯÚÖÁ¾ø¾­ºóÒ»ÄꡣΧ¾ø¾­ÆÚ×ÛºÏÕ÷ÊÇÓÉÓÚÂѳ²¹¦Ð§¼õÍË£¬µ¼Ö´Ƽ¤ËØÉøÍ¸ïÔÌ­£¬ÒýÆð»úÌåÄÚÉøÍ¸Ê§µ÷¡¢ÃâÒßÁ¦µÍϺÍ×ÔÖ÷Éñ¾­¹¦Ð§ÔÓÂÒµÄ×ÛºÏÕ÷¡£ÁÙ´²Éϳ£¼û³±ÈÈÀ亹¡¢Ô¾­ÔÓÂÒ¡¢¾«Éñ״̬µÄת±ä¡¢ÐÄѪ¹ÜÓëÉúÖ³ÃÚÄòϵͳ²¡±ä¼°¹ÇÖÊËÉÉ¢µÈÌåÏÖ¡£³£ÓõÄΧ¾ø¾­ÆÚ×ÛºÏÕ÷¶¯ÎïÄ£×ÓÓÐÂѳ²Õª³ýÄ£×Ó¡¢×ÔÈ»ÀÏ»¯Ä£×Ó¡¢XÏßËðÉËÂѳ²Ä£×ӵȡ£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î´óÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

12ÔÂÁäǰºó(11-13ÔÂÁ䣩µÄ´ÆÐÔ´óÊó£¬×îÏÈ·ºÆð¶¯ÇéÖÜÆÚÔÓÂÒ£¬ÑªÇåѧ¼°Âѳ²ÏìÓ¦µÄÉú»¯Ö¸±êµÈ¾ùÏÔʾ£¬¸Ã½×¶Î´óÊóÂѳ²µÄÉúÖ³¹¦Ð§³Ê¾ÙÐÐÐÔË¥Í˵ĸı䣬ÓëÅ®ÐÔΧ¾ø¾­ÆÚÌåÏÖ¼«ÎªÏàËÆ£¬¿É×÷ΪΧ¾ø¾­ÆÚÂѳ²ÐàÂõÑо¿µÄ¶¯ÎïÄ£×Ó¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

12ÔÂÁäǰºóµÄ´ÆÐÔSprague­Dawley´óÊó»òWistar´óÊóÈô¸ÉÖ»£¬Ò»Á¬ÒõµÀϸ°ûѧÊÓ²ì15Ì죬ѡȡ¶¯ÇéÖÜÆÚ·ºÆðÁËÑÓÉì¼°ÔÓÂÒÌåÏÖµÄΪģ×Ó×飬°üÀ¨¶¯ÇéÖÜÆÚÑÓÉ죬֮ºóÒ»Á¬¶¯Ç飬Öظ´¼ÙÈÑÉï¡£´óÊóÐÔ³ÉÊìºó£¬¶¯ÇéÖÜÆÚÿ¾­4~5ÖçÒ¹½ÚÂÉÐÔµØÖظ´Ò»´Î£¬ÔÚÕâ¸öÀú³ÌÖÐÂѳ²µÄÂÑÅÝ¡¢×Ó¹¬ºÍÒõµÀÉÏÆ¤¶¼ÂÄÀú×ÅÖÜÆÚÐÔµÄת±ä£¬¶¯ÇéÆÚ¿É¼û´ó¶øµ­È¾µÄÎ޺˽ǻ¯Ï¸°û£¬¶¯Çé¼äÆÚÒõµÀÉÏÆ¤Öð½¥Ôöºñ£¬Ï¸°û¼äÓÐÐí¶à°×ϸ°û¡£ÒõµÀÍÑÂäϸ°ûͿƬҪÁ죺×óÊÖ±³Î»Àο¿´óÊó£¬ÓÒÊÖ³ÖÎü¹Ü£¬ÆäÄÚÔ¤ÏÈÎüÈëÐÄÀíÑÎË®0.1~0.2ml¡£ÇáÇá²åÈë´óÊóÒõµÀÄÚ0.5~1cm£¬³éÎü2~3´Î£¬µÎÒ»µÎÎüÒºÓÚÔØ²£Æ¬ÉÏ¡£È»ºóµÎÒ»µÎ95£¥ÒÒ´¼ÈÜÒº£¬ÁÀ¸ÉºóÒÔ1£¥ÑǼ×À¶È¾É«10·ÖÖÓ£¬ÓÃË®³åÏ´¶àÓàȾҺ¡£´µ¸ÉºóÖÃÓÚÏÔ΢¾µÏ¾ÙÐÐϸ°ûѧ¼ì²é¡£ÖðÖ»¾ÙÐÐÒõµÀͿƬ¼ì²é£¬Ã¿1´Î£¬Ò»Á¬15Ìì¡£

¡¾Ä£×ÓÌØµã¡¿£º

1.Âѳ²×éÖ¯µÄÐÎ̬ѧÊÓ²ì

¢Å¹â¾µÊÓ²ìЧ¹û£ºÇàÄê±ÈÕÕ×é´óÊóÂѳ²·¢Óý³ÉÊ죬ƤÖÊ¡¢ËèÖÊÌõÀíÃ÷È·£¬ÆäÖи÷¼¶ÂÑÅݼ°»ÆÌåÊýÄ¿¾ù½Ï¶à£¬ÂÑÅÝÒº¸»ºñ£¬¿É¼ûÉÙÁ¿±ÕËøÂÑÅݼ°¼äÖÊÏÙ¡£Ä£×Ó×é´óÊóÂѳ²Î®Ëõ£¬·¢Óý½Ï²î£¬ËèÖÊÔö¶à£¬Ô­Ê¼ÂÑÅݺÍÉú³¤ÂÑÅݾùÏÔ×ÅïÔÌ­£¬¿ÅÁ£Ï¸°ûÅÅÁв»¹æÕû£¬¿É¼û¿ÅÁ£Ï¸°ûµÄ±À½â£¬Î´¼ûµä·¶µÄ³ÉÊìÂÑÅÝ£¬±ÕËøÂÑÅÝÊýÄ¿ÔöÌí£»³ÉÊì»ÆÌåÊýĿҲ½ÏÉÙ£¬¶øÍË»¯»ÆÌåÊýÄ¿Ôö¶à£¬¼äÖÊÏÙÉÙ¶øËÉÉ¢£¬¿É¼ûÏËά×éÖ¯ÔöÉú»ò±À½â£¬Ñª¹ÜÊýÄ¿ïÔÌ­£¬Ð¡¶¯Âö¹ÜÇ»ÏÁÕ­¡¢¹£Èû¡£

¢Æµç¾µÊÓ²ìЧ¹û£ºÇàÄê×é±ÈÕÕÂѳ²Ô­Ê¼ÂÑÅݸ»ºñ£¬ÂÑĸϸ°ûÌå»ý½Ï´ó£¬ºËÖÊÔȳơ¢ºËÈÊÏÔ×Å£¬ÖÜΧµ¥²ã¿ÅÁ£Ï¸°ûºË²»¹æÔò£¬ºËĤÄÚÓб¡²ãÒìȾɫÌ壻Éú³¤ÂÑÅÝÖпɼû͸Ã÷´øÔö¿í£¬¿ÅÁ£Ï¸°û³Ê¶à²ãÂþÑÜ£¬ºË´óµ­È¾£¬ºËÈÊÏÔ×Å£¬È¾É«ÖÊÔȳÆ£¬Ï¸°ûÆ÷ÍêÕû£¬ÂÖÀªÇåÎú£¬°ûÖÊÖÐϸ°ûÆ÷¸»ºñ£¬¿É¼ûÉøÍ¸¿ÅÁ££» ϸ°û¼äÓÐñ¼×´¼ä϶¡£Ä£×Ó×éÂѳ²¿ÅÁ£Ï¸°ûÖÐÓн϶à¿ÕÅÝ£¬ÉøÍ¸¿ÅÁ£ïÔÌ­£¬ÆäÖпɼûÖÂÃÜÎ»¬ÃæÄÚÖÊÍø²»¸»ºñ£¬Ï¸°û¼äµÄñ¼×´¼ä϶Ôö´ó£»¼äÖʿɼûÏËά¡¢»ùÖÊÏûÈÚ¡£

2.Ä£×Ó×éÓëÇàÄê±ÈÕÕ×éÏà±È£¬ÑªÇå´ÙÂÑÅÝÌìÉú¼¤ËØFSH¡¢´Ù»ÆÌåÌìÉúËØLH¡¢´ÙÐÔÏÙ¼¤ËØÊͷż¤ËØGnRHˮƽÉý¸ß£¬ÑªÇå´Æ¼¤ËØE2ˮƽ½µµÍ£»Ä£×Ó×é½ÏÇàÄê±ÈÕÕ×éÂѳ²Ö¸ÊýÓë×Ó¹¬Ö¸ÊýÏÔÖø½µµÍ£»ÒÔÉϾùÓÐÏÔÖø²î±ð(P<0.05)¡£

3.Χ¾ø¾­ÆÚ¸¾Å®ÓÉÓÚÂѳ²¹¦Ð§Ë¥ÍË£¬´Æ¼¤ËØË®Æ½Ï½µ£¬ÑªÖÐ×ܵ¨¹Ì´¼¡¢¸ÊÓÍÈýõ¥¡¢µÍÃܶÈÖ¬ÂѰ׵¨¹Ì´¼ÔöÌí¡£¶øÑªÖ¬´úлÒì³£Êǵ¼Ö¶¯ÂöÖàÑùÓ²»¯(atheroscbrasis)¡¢¹ÚÐIJ¡(coronary heart disease)µÄÖ÷ÒªÔµ¹ÊÔ­ÓÉ¡£±¾Ä£×Ó¶¯ÎïµÄѪÇå×ܵ¨¹Ì´¼¡¢ÑªÇå¸ÊÓÍÈýõ¥¡¢Ñªáú½éÃܶÈÖ¬ÂѰ׵¨¹Ì´¼¡¢ÑªÇåµÍÃܶÈÖ¬ÂѰ׵¨¹Ì´¼µÈˮƽ¾ùÓëÇàÄê×éÓÐÏÔÖø²î±ð£¬ºÜÊÇÇкÏΧ¾ø¾­ÆÚµÄÌØµã£¬±¾Ä£×ÓÊÇÀֳɵÄ¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

×ÔÈ»ÀÏ»¯Ä£×ÓÓëÈËΧ¾ø¾­ÆÚÉúÎïÑ§ÌØÕ÷Ïà·Â£¬ÓÐ×ÔÈ»µÄÐàÂõÀú³Ì£¬ÊÇÂѳ²¹¦Ð§µÄË¥½ß¶ø²»ÊÇÂѳ²Õª³ý£¨È¥ÊÆ£©£¬ÒÔÊǸü¿¿½üÓÚÊÂʵ×Ô¼º£¬ÊǽÏΪÀíÏëµÄÄ£×Ó¡£ÈõµãÊÇÖÜÆÚ³¤£¬Óöȸß¡£

 

²Î¿¼ÎÄÏ×£º

1.Íõ»ª¸»£¬Ðí»ÝÇÙ£¬³ÂÃôÃô£¬µÈ£®°ÙºÏ֪ĸÌÀ²î±ðÅä±È¶ÔÈ¥ÊÆÎ§¾ø¾­ÆÚ×ÛºÏÕ÷ÉöÒõÐéÖ¤´óÊó×Ó¹¬ÏµÊý¼°ÑªÇåÐÔ¼¤ËصÄÓ°Ï죮ÖлªÖÐÒ½Ò©ÔÓÖ¾£¬2010, 25 (4):531-535

2.ÇúÏÔ¿¡£¬´ÞÊçÏ㣬Àî·çÇÙ£¬µÈ£®¹ÇÎ¬ËØ×¢ÉäÒº¶ÔXÏßÖ´óÊó¸üÄêÆÚ×ÛºÏÕ÷Ä£×ÓµÄÖÎÁÆ×÷ÓÃÊӲ죮ɽ¶«Ò½Ò©¹¤Òµ£¬1998, 17 (4):123-128

3.ËïÑ޺죬½ðÈôÃô£®Å®ÐÔ¸üÄêÆÚ×ÛºÏÕ÷¶¯ÎïÄ£×ÓÖÆ±¸µÄÑо¿Ï£Íû£®Ê±Õä¹úÒ½¹úÒ©£¬2005, 16 (7):657-659

4.Ëï¾²·Ú£¬ÕÔìÇ£¬ÎâËØ»Û£®Î§¾ø¾­ÆÚ×ÛºÏÕ÷ʵÑ鶯ÎïÄ£×ӵĽÏÁ¿ÆÊÎö£®É½Î÷Ò½¿Æ´óѧѧ±¨£¬2007,38 (1):43-45

5.ÃÏÒ㣬ÅÓº£Ñ࣬Áõ¹úÒÕ£¬µÈ£®´ó¶¹Òì»ÆÍª¶ÔΧ¾ø¾­ÆÚ´óÊóÂѳ²×éÖ¯ÐÎ̬ѧת±ä¼°SPARCmRNA±í´ïµÄÓ°Ïì, ÖйúÖÐÒ½Ò©¿Æ¼¼£¬2012, 19(1):32-34

6.ÀµÇ«¿­£¬Õž²£¬ÕÅÏþµ¤£®°²¶È¸üÄêÍè¶ÔΧ¾ø¾­ÆÚSD´óÊóÐÔ¼¤Ëؼ°ÑªÖ¬´úлӰÏìµÄʵÑéÑо¿£®ÖÐÒ½ÁÙ´²Ñо¿£¬2012,4 (9):29-31

7.Bellino FL, Wise PM. Nonhuman primate models of menopause workshop. Biol Reprod, 2003, 68 (1):10-18

8.Mayer LP, Oyer CA, Eastgard RL, el al. Atherosclerotic lesion development in a novel ovary-intact mouse model of perimenopause. Arterioscler Thromb Vasc Biol, 2005, 25 (9):1910-1916

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿